Company / Revenue
ImageneBio, Inc. Revenue History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$3.5M
FY2025
5-year range
$3.5M / $31.0M
FY2021-FY2025
Trend
-61.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has declined for 3 consecutive years, from $31M in FY2022 to $4M in FY2025.
Based on SEC 10-K filings.
$4M in FY2025 with a 3-year CAGR of -51.7%.
Declined from $16M to $4M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -51.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ImageneBio, Inc.'s revenue has declined for 3 consecutive years.
- 3-year CAGR of -51.7%, indicating a declining trend.
- In FY2025, revenue decreased 61.8% year-over-year.
- Peak revenue was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.5M | -61.8% |
| FY2024 | $9.2M | -41.3% |
| FY2023 | $15.6M | -49.6% |
| FY2022 | $31.0M | +237.0% |
| FY2021 | $9.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026